Skip to main content
NIH funding notice RFA-AR-14-015

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)

Closed on May 21, 2014.

Posted
March 21, 2014
Close date
May 21, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,092,002 in first-year total cost, median $1,046,001.

Most frequent study sections

  1. Special Emphasis Panel[ZAR1 CNR (M1)]2

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
  2. STANFORD UNIVERSITY1
Competing awards under RFA-AR-14-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014AMP RA/SLE Leadership Center1UM2AR067678-01HOLERS, VERNON MICHAELUTZ, PAUL JOSEPHSTANFORD UNIVERSITY, CA$1,640,001ZAR1
2014RA-SLE Molecular Deconstruction Leadership Center1UH2AR067677-01BRENNER, MICHAEL B.RAYCHAUDHURI, SOUMYABRIGHAM AND WOMEN'S HOSPITAL, MA$452,001ZAR1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.